Page last updated: 2024-10-22

alprenolol and Psoriasis

alprenolol has been researched along with Psoriasis in 1 studies

Alprenolol: One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.
alprenolol : A secondary alcohol that is propan-2-ol substituted by a 2-allylphenoxy group at position 1 and an isopropylamino group at position 3. It is a beta-adrenergic antagonist used as a antihypertensive, anti-arrhythmia and a sympatholytic agent.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Itami, S1
Kino, J1
Halprin, KM1
Adachi, K1

Other Studies

1 other study available for alprenolol and Psoriasis

ArticleYear
Immunohistochemical study of beta-adrenergic receptors in the psoriatic epidermis using an anti-alprenolol anti-idiotypic antibody.
    Archives of dermatological research, 1987, Volume: 279, Issue:7

    Topics: Alprenolol; Animals; Antibodies, Monoclonal; Antibody Formation; Epidermis; Immunization; Immunoglob

1987